Format

Send to

Choose Destination
See comment in PubMed Commons below
Rheum Dis Clin North Am. 1998 Aug;24(3):465-77.

Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis.

Author information

1
Department of Medicine, University of Nebraska Medical Center, Omaha, USA.

Abstract

Combinations of DMARDs are currently used to treat rheumatoid arthritis by almost all rheumatologists. This article reviews the published data on the triple combination of methotrexate, sulfasalazine, and hydroxychloroquine, discusses caveats for clinical use, compares efficacy of different combinations, and speculates on future combination therapies.

PMID:
9710881
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center